Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors
The prevalence of antibodies to hepatitis C virus (anti-HCV) was retrospectively determined using a second generation enzyme immunoassay in 3868 blood donors from the southern part of Saudi Arabia in an area with high prevalence of hepatitis B virus (HBV) infection. Of 3354 Saudis, 48 (1.43%) were s...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1995-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1995/947681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546513863049216 |
|---|---|
| author | Bandar Al-Knawy Awad A El-Mekki Jamal Hamdi Raja Thiga Anwar Sheikha |
| author_facet | Bandar Al-Knawy Awad A El-Mekki Jamal Hamdi Raja Thiga Anwar Sheikha |
| author_sort | Bandar Al-Knawy |
| collection | DOAJ |
| description | The prevalence of antibodies to hepatitis C virus (anti-HCV) was retrospectively determined using a second generation enzyme immunoassay in 3868 blood donors from the southern part of Saudi Arabia in an area with high prevalence of hepatitis B virus (HBV) infection. Of 3354 Saudis, 48 (1.43%) were seropositive for anti-HCV. A high prevalence (43 of 204, 21.08%) of anti-HCV was observed among Egyptian donors compared with Saudis (1.43%) and other nationalities (eight of 310, 2.58%). Furthermore, the prevalence of anti-HCV antibodies was observed to increase with age, peaking in the 25 to 34 year age group. From this and other studies conducted in different regions of Saudi Arabia, the prevalence of anti-HCV among Egyptian donors appears to range from 19.2 to 24.5%, and among Saudi donors appears to range from 1.00 to 1.7%, a rate similar to that reported from western countries; this latter rate does not seem to be influenced by the high prevalence of HBV infection in this region. |
| format | Article |
| id | doaj-art-25f388e2a2114c3385a5feed0f4315c3 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 1995-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-25f388e2a2114c3385a5feed0f4315c32025-02-03T06:48:38ZengWileyCanadian Journal of Gastroenterology0835-79001995-01-019314114310.1155/1995/947681Prevalence of Antibody to Hepatitis C Virus in Saudi Blood DonorsBandar Al-Knawy0Awad A El-Mekki1Jamal Hamdi2Raja Thiga3Anwar Sheikha4Departments of Medicine, Gastroenterology Unit, Clinical Microbiology and Parasitology, Surgery and Haematology, College of Medicine, King Saud University, Saudi ArabiaDepartments of Medicine, Gastroenterology Unit, Clinical Microbiology and Parasitology, Surgery and Haematology, College of Medicine, King Saud University, Saudi ArabiaDepartments of Medicine, Gastroenterology Unit, Clinical Microbiology and Parasitology, Surgery and Haematology, College of Medicine, King Saud University, Saudi ArabiaDepartments of Medicine, Gastroenterology Unit, Clinical Microbiology and Parasitology, Surgery and Haematology, College of Medicine, King Saud University, Saudi ArabiaDepartments of Medicine, Gastroenterology Unit, Clinical Microbiology and Parasitology, Surgery and Haematology, College of Medicine, King Saud University, Saudi ArabiaThe prevalence of antibodies to hepatitis C virus (anti-HCV) was retrospectively determined using a second generation enzyme immunoassay in 3868 blood donors from the southern part of Saudi Arabia in an area with high prevalence of hepatitis B virus (HBV) infection. Of 3354 Saudis, 48 (1.43%) were seropositive for anti-HCV. A high prevalence (43 of 204, 21.08%) of anti-HCV was observed among Egyptian donors compared with Saudis (1.43%) and other nationalities (eight of 310, 2.58%). Furthermore, the prevalence of anti-HCV antibodies was observed to increase with age, peaking in the 25 to 34 year age group. From this and other studies conducted in different regions of Saudi Arabia, the prevalence of anti-HCV among Egyptian donors appears to range from 19.2 to 24.5%, and among Saudi donors appears to range from 1.00 to 1.7%, a rate similar to that reported from western countries; this latter rate does not seem to be influenced by the high prevalence of HBV infection in this region.http://dx.doi.org/10.1155/1995/947681 |
| spellingShingle | Bandar Al-Knawy Awad A El-Mekki Jamal Hamdi Raja Thiga Anwar Sheikha Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors Canadian Journal of Gastroenterology |
| title | Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors |
| title_full | Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors |
| title_fullStr | Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors |
| title_full_unstemmed | Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors |
| title_short | Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors |
| title_sort | prevalence of antibody to hepatitis c virus in saudi blood donors |
| url | http://dx.doi.org/10.1155/1995/947681 |
| work_keys_str_mv | AT bandaralknawy prevalenceofantibodytohepatitiscvirusinsaudiblooddonors AT awadaelmekki prevalenceofantibodytohepatitiscvirusinsaudiblooddonors AT jamalhamdi prevalenceofantibodytohepatitiscvirusinsaudiblooddonors AT rajathiga prevalenceofantibodytohepatitiscvirusinsaudiblooddonors AT anwarsheikha prevalenceofantibodytohepatitiscvirusinsaudiblooddonors |